Côté HC - Search Results

1

Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.

Côté HC. Côté HC. Antivir Ther. 2005;10 Suppl 2:M3-11. Antivir Ther. 2005. PMID: 16152702 Review.

2

Clinical utility of testing human immunodeficiency virus for drug resistance.

Harrigan PR, Côté HC. Harrigan PR, et al. Among authors: cote hc. Clin Infect Dis. 2000 Jun;30 Suppl 2:S117-22. doi: 10.1086/313861. Clin Infect Dis. 2000. PMID: 10860895 Review.

3

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS. Côté HC, et al. N Engl J Med. 2002 Mar 14;346(11):811-20. doi: 10.1056/NEJMoa012035. N Engl J Med. 2002. PMID: 11893792 Free article.

4

Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens.

Côté HC, Yip B, Asselin JJ, Chan JW, Hogg RS, Harrigan PR, O'Shaughnessy MV, Montaner JS. Côté HC, et al. J Infect Dis. 2003 Jun 15;187(12):1972-6. doi: 10.1086/375353. Epub 2003 May 29. J Infect Dis. 2003. PMID: 12792876

5

Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV. Montaner JS, et al. Among authors: cote hc. J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S85-90. doi: 10.1097/00126334-200309011-00013. J Acquir Immune Defic Syndr. 2003. PMID: 14562863 Review.

6

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV. Montaner JS, et al. Among authors: cote hc. Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S73-9. doi: 10.1086/381449. Clin Infect Dis. 2004. PMID: 14986278

7

Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both.

Ballesteros AL, Miró O, López S, Fuster D, Videla S, Martínez E, Garrabou G, Salas A, Côté H, Tor J, Rey-Joly C, Planas R, Clotet B, Tural C. Ballesteros AL, et al. Antivir Ther. 2004 Dec;9(6):969-77. Antivir Ther. 2004. PMID: 15651755 Clinical Trial.

8

Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.

Côté HC, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, Yu E, Yip B, Zalunardo N, Werb R, Hogg R, Harrigan PR, Montaner JS. Côté HC, et al. Antivir Ther. 2006;11(1):79-86. Antivir Ther. 2006. PMID: 16518963

9

Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin.

Schick BA, Laaksonen R, Frohlich JJ, Päivä H, Lehtimäki T, Humphries KH, Côté HC. Schick BA, et al. Among authors: cote hc. Clin Pharmacol Ther. 2007 May;81(5):650-3. doi: 10.1038/sj.clpt.6100124. Epub 2007 Feb 28. Clin Pharmacol Ther. 2007. PMID: 17329991 Clinical Trial.

10

Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells.

Papp E, Gadawski I, Côté HC. Papp E, et al. Among authors: cote hc. J Antimicrob Chemother. 2008 May;61(5):1048-52. doi: 10.1093/jac/dkn067. Epub 2008 Feb 28. J Antimicrob Chemother. 2008. PMID: 18310046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters